Seiichi Nagano
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Single-nucleus multiome shows motor neuron glutamate overactivation in amyotrophic lateral sclerosis.
Journal: Brain : a journal of neurology
Published: March 01, 2025
Conformational Switch in the Alpha-Synuclein C-Terminal Domain Directs Its Fibril Polymorphs.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: February 19, 2025
TDP-43 transports ferritin heavy chain mRNA to regulate oxidative stress in neuronal axons.
Journal: Neurochemistry international
Published: October 23, 2024
Accelerated senescence exacerbates α-synucleinopathy in senescence-accelerated prone 8 mice via persistent neuroinflammation.
Journal: Neurochemistry international
Published: September 29, 2024
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 26, 2023
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS.
Journal: Science advances
Published: November 22, 2023
Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.
Journal: Acta neuropathologica communications
Published: September 01, 2023
Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders.
Journal: Cells
Published: January 11, 2023
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Journal: Acta neuropathologica
Published: October 04, 2022
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.
Journal: JMIR research protocols
Published: August 24, 2022
Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice.
Journal: Molecular therapy. Nucleic acids
Published: April 22, 2022
Last Updated: 09/26/2026